Recently, Qiu et al have indentified IOI-42 as the first chemical inhibitor of hPEBP4 and have shown that IOI-42 can sensitize tumor cells to TNF-α and TRAIL-mediated apoptosis by targeting hPEBP4 [20]. The gene discussed is PEBP4; the disease is neoplasm.